Demant A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WILYY research report →
About the company
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019.
- CEO
- Søren Nielsen
- IPO
- 2011
- Employees
- 25,077
- HQ
- Smorum, DK
Price Chart
- Market Cap
- $8.71B
- P/E
- 38.24
- P/S
- 2.58
- P/B
- 6.03
- EV/EBITDA
- 15.90
- Div Yield
- 0.00%
- Gross Margin
- 69.86%
- Op Margin
- 17.63%
- Net Margin
- 6.70%
- ROE
- 16.06%
- ROIC
- 9.22%
- Revenue
- $22.97B · 2.46%
- Net Income
- $1.54B · -35.27%
- EPS
- $3.52 · -35.50%
- Op Income
- $3.91B
- FCF YoY
- -3.81%
- 52W High
- $21.08
- 52W Low
- $13.45
- 50D MA
- $18.51
- 200D MA
- $16.87
- Beta
- 0.75
- Avg Volume
- 177
Get TickerSpark's AI analysis on WILYY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our WILYY coverage
Recent articles, reports, and earnings notes.
No research on WILYY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WILYY report →Similar companies
Peers in the same neighborhood.